Recipharm equips Lisbon facility for US and European serialisation

Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped its sixth facility with serialisation capabilities ahead of the US and European regulation enforcement deadlines.

Nanobiotix completes patient inclusion for Phase II/III trial of NBTXR3 in soft tissue Sarcoma

NANOBIOTIX announced that it has completed patient inclusion for the Phase II/III trial (Act.In.Sarc) of its lead product candidate, NBTXR3, in soft tissue sarcoma.

Vetter To Expand its Secondary Packaging Service Capacity to Meet Rising Demands

Vetter announced a major expansion of its secondary packaging capacities as a response to rising customer needs and market demands for complex packaging....

New Unrivalled Capabilities Take GC-MS to the Next Level of Performance

Updated with new capabilities in high resolution accurate mass GC-MS, the Thermo Scientific Orbitrap GC-MS systems now give users across metabolomics, food safety, environmental, pharma and toxicology applications high levels of accuracy...

DCPrime and apceth Biopharma GmbH Announce Manufacturing Partnership

DCPrime BV, a clinical stage company developing dendritic cell vaccines to treat cancer, and apceth Biopharma GmbH, an established contract manufacturing organization in the field of cell...

The NKI awarded funding to apply molecular imaging technology to prostate cancer surgery

The Netherlands Cancer Institute (NKI) announced that it has received funding from the Dutch Cancer Society to test whether a novel molecular imaging technology...

For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
or
call to: + 91 88268 49084

If you like to receive our latest Media Pack 2017 / Editorial Calender please click here

For the latest visit: www.worldpharmatoday.com